Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket
Description
To identify starting points for therapeutics targeting SARS-CoV-2, the Paul Scherrer Institute and Idorsia decided to collaboratively perform an X-ray crystallographic fragment screen against its main protease. Fragment-based screening was carried